High-dose chemotherapy with support by autologous bone marrow and GM-CSF in the treatment of advanced ovarian cancer: preliminary report of a new strategy.
Yen
M L
ML
Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei, ROC.
Chen
Y C
YC
Lin
M T
MT
Liu
M C
MC
Tang
J L
JL
Wang
C H
CH
Hsieh
C Y
CY
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D016026:Bone Marrow Transplantation / Q000379:methods*; D016190:Carboplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D008558:Melphalan / Q000008:administration & dosage; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D010976:Platelet Count; D011446:Prospective Studies
D015295:Antigens, Tumor-Associated, Carbohydrate; D000970:Antineoplastic Agents; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D016190:Carboplatin; D008558:Melphalan